677 related articles for article (PubMed ID: 21533301)
21. Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer.
Ma L; Li P; Tang J; Guo Y; Shen C; Chang J; Kerrouche N
Adv Ther; 2017 Dec; 34(12):2601-2611. PubMed ID: 29143926
[TBL] [Abstract][Full Text] [Related]
22. The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.
Janmohamed SR; Oranje AP; Devillers AC; Rizopoulos D; van Praag MC; Van Gysel D; Goeteyn M; de Waard-van der Spek FB
J Am Acad Dermatol; 2014 Jun; 70(6):1076-82. PubMed ID: 24698702
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis.
Sugarman JL; Parish LC
J Drugs Dermatol; 2009 Dec; 8(12):1106-11. PubMed ID: 20027938
[TBL] [Abstract][Full Text] [Related]
24. Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.
Weber TM; Samarin F; Babcock MJ; Filbry A; Rippke F
J Drugs Dermatol; 2015 May; 14(5):478-85. PubMed ID: 25942666
[TBL] [Abstract][Full Text] [Related]
25. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
Belloni G; Pinelli S; Veraldi S
Eur J Dermatol; 2005; 15(1):31-6. PubMed ID: 15701590
[TBL] [Abstract][Full Text] [Related]
26. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study.
Udompataikul M; Srisatwaja W
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):660-5. PubMed ID: 20840345
[TBL] [Abstract][Full Text] [Related]
27. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
28. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
Emer JJ; Frankel A; Sohn A; Lebwohl M
J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
[TBL] [Abstract][Full Text] [Related]
29. A cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis.
Lynde CW; Andriessen A
Cutis; 2014 Apr; 93(4):207-13. PubMed ID: 24818182
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle-controlled trial.
Korting HC; Schöllmann C; Cholcha W; Wolff L;
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1176-82. PubMed ID: 20236198
[TBL] [Abstract][Full Text] [Related]
31. Improvement in pruritus in children with atopic dermatitis using pimecrolimus cream 1%.
Fowler J; Johnson A; Chen M; Abrams K
Cutis; 2007 Jan; 79(1):65-72. PubMed ID: 17330625
[TBL] [Abstract][Full Text] [Related]
32. Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study.
Udompataikul M; Limpa-o-vart D
J Drugs Dermatol; 2012 Mar; 11(3):366-74. PubMed ID: 22395588
[TBL] [Abstract][Full Text] [Related]
33. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
34. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
[TBL] [Abstract][Full Text] [Related]
35. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
36. Superiority of a vitamin B12-barrier cream compared with standard glycerol-petrolatum-based emollient cream in the treatment of atopic dermatitis: A randomized, left-to-right comparative trial.
Nistico SP; Del Duca E; Tamburi F; Pignataro E; De Carvalho N; Farnetani F; Pellacani G
Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28677237
[TBL] [Abstract][Full Text] [Related]
37. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
38. Barrier repair therapy for facial atopic eczema with a non-steroidal emollient cream containing rhamnosoft, ceramides and iso-leucine. A six-case report series.
Puviani M; Agostinis F; Milani M
Minerva Pediatr; 2014 Aug; 66(4):307-11. PubMed ID: 25198568
[TBL] [Abstract][Full Text] [Related]
39. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
Chamlin SL; Kao J; Frieden IJ; Sheu MY; Fowler AJ; Fluhr JW; Williams ML; Elias PM
J Am Acad Dermatol; 2002 Aug; 47(2):198-208. PubMed ID: 12140465
[TBL] [Abstract][Full Text] [Related]
40. Evidence-based treatment of atopic dermatitis with topical moisturizers.
Micali G; Paternò V; Cannarella R; Dinotta F; Lacarrubba F
G Ital Dermatol Venereol; 2018 Jun; 153(3):396-402. PubMed ID: 29368843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
